

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | endothelium development (GO:0003158) | 6.67653727 |
| 2 | presynaptic membrane assembly (GO:0097105) | 6.09942047 |
| 3 | C4-dicarboxylate transport (GO:0015740) | 5.70501875 |
| 4 | amino acid import (GO:0043090) | 5.66526927 |
| 5 | L-amino acid import (GO:0043092) | 5.39605338 |
| 6 | lymph vessel development (GO:0001945) | 5.33960224 |
| 7 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 5.22272831 |
| 8 | regulation of cardiac muscle cell contraction (GO:0086004) | 5.21735999 |
| 9 | presynaptic membrane organization (GO:0097090) | 5.18841649 |
| 10 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 5.04866596 |
| 11 | cellular sodium ion homeostasis (GO:0006883) | 4.97880633 |
| 12 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 4.95234392 |
| 13 | alanine transport (GO:0032328) | 4.95111629 |
| 14 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 4.87625823 |
| 15 | layer formation in cerebral cortex (GO:0021819) | 4.54345445 |
| 16 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 4.50616982 |
| 17 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 4.44840252 |
| 18 | auditory behavior (GO:0031223) | 4.35417243 |
| 19 | vascular endothelial growth factor signaling pathway (GO:0038084) | 4.23023989 |
| 20 | regulation of synapse structural plasticity (GO:0051823) | 4.08537422 |
| 21 | dermatan sulfate biosynthetic process (GO:0030208) | 4.07865025 |
| 22 | regulation of actin filament-based movement (GO:1903115) | 3.98361709 |
| 23 | endothelial cell differentiation (GO:0045446) | 3.88917529 |
| 24 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.83793509 |
| 25 | L-serine transport (GO:0015825) | 3.79004323 |
| 26 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.75585551 |
| 27 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.75468898 |
| 28 | potassium ion import (GO:0010107) | 3.72989479 |
| 29 | response to auditory stimulus (GO:0010996) | 3.71189039 |
| 30 | vocalization behavior (GO:0071625) | 3.67608145 |
| 31 | oligodendrocyte differentiation (GO:0048709) | 3.65390820 |
| 32 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.64990114 |
| 33 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.55277971 |
| 34 | positive regulation of dendritic spine development (GO:0060999) | 3.53863923 |
| 35 | gamma-aminobutyric acid transport (GO:0015812) | 3.53243390 |
| 36 | negative regulation of astrocyte differentiation (GO:0048712) | 3.51336075 |
| 37 | cellular response to cholesterol (GO:0071397) | 3.44257378 |
| 38 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.41328448 |
| 39 | blood vessel maturation (GO:0001955) | 3.38399463 |
| 40 | positive regulation of vasculogenesis (GO:2001214) | 3.33058813 |
| 41 | locomotory exploration behavior (GO:0035641) | 3.30261759 |
| 42 | mechanosensory behavior (GO:0007638) | 3.28227507 |
| 43 | chondroitin sulfate catabolic process (GO:0030207) | 3.28018282 |
| 44 | cellular potassium ion homeostasis (GO:0030007) | 3.27370306 |
| 45 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 3.26130346 |
| 46 | regulation of beta-amyloid formation (GO:1902003) | 3.20110963 |
| 47 | serine transport (GO:0032329) | 3.19829417 |
| 48 | regulation of vasculogenesis (GO:2001212) | 3.19751131 |
| 49 | proline transport (GO:0015824) | 3.19476566 |
| 50 | cerebellar granule cell differentiation (GO:0021707) | 3.18891560 |
| 51 | cochlea development (GO:0090102) | 3.16378188 |
| 52 | neuron recognition (GO:0008038) | 3.13816697 |
| 53 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.12050351 |
| 54 | atrial cardiac muscle cell action potential (GO:0086014) | 3.12020439 |
| 55 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.09928125 |
| 56 | synaptic vesicle exocytosis (GO:0016079) | 3.09557056 |
| 57 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.07813474 |
| 58 | regulation of respiratory system process (GO:0044065) | 3.06217617 |
| 59 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 3.04047858 |
| 60 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.02888253 |
| 61 | microglial cell activation (GO:0001774) | 3.02823173 |
| 62 | cAMP-mediated signaling (GO:0019933) | 3.00061909 |
| 63 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.00024677 |
| 64 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.99574877 |
| 65 | heart trabecula morphogenesis (GO:0061384) | 2.99218326 |
| 66 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.98902835 |
| 67 | axon ensheathment in central nervous system (GO:0032291) | 2.98123403 |
| 68 | central nervous system myelination (GO:0022010) | 2.98123403 |
| 69 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.97729265 |
| 70 | glial cell proliferation (GO:0014009) | 2.96580219 |
| 71 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.95968118 |
| 72 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.95020526 |
| 73 | acidic amino acid transport (GO:0015800) | 2.92927728 |
| 74 | cell communication involved in cardiac conduction (GO:0086065) | 2.91794312 |
| 75 | sodium ion homeostasis (GO:0055078) | 2.91467371 |
| 76 | membrane repolarization (GO:0086009) | 2.90507383 |
| 77 | membrane depolarization during action potential (GO:0086010) | 2.90327707 |
| 78 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.90033780 |
| 79 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.89470478 |
| 80 | negative regulation of neurotransmitter transport (GO:0051589) | 2.88031245 |
| 81 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.86761296 |
| 82 | otic vesicle formation (GO:0030916) | 2.86114195 |
| 83 | serotonin metabolic process (GO:0042428) | 2.84822760 |
| 84 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.84429658 |
| 85 | cellular response to sterol (GO:0036315) | 2.83889865 |
| 86 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.83209321 |
| 87 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.79689845 |
| 88 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.78915818 |
| 89 | regulation of astrocyte differentiation (GO:0048710) | 2.78187690 |
| 90 | heart valve formation (GO:0003188) | 2.76927322 |
| 91 | positive regulation of potassium ion transport (GO:0043268) | 2.76845830 |
| 92 | protein localization to synapse (GO:0035418) | 2.76481945 |
| 93 | phenol-containing compound catabolic process (GO:0019336) | 2.76386390 |
| 94 | patterning of blood vessels (GO:0001569) | 2.72974714 |
| 95 | regulation of dendritic spine development (GO:0060998) | 2.71713202 |
| 96 | relaxation of cardiac muscle (GO:0055119) | 2.71210296 |
| 97 | synaptic vesicle maturation (GO:0016188) | 2.71192911 |
| 98 | fatty acid elongation (GO:0030497) | 2.70005071 |
| 99 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.69493479 |
| 100 | cerebellar Purkinje cell layer development (GO:0021680) | 2.69183194 |
| 101 | limb bud formation (GO:0060174) | 2.68262404 |
| 102 | modified amino acid transport (GO:0072337) | 2.67227815 |
| 103 | glutamate receptor signaling pathway (GO:0007215) | 2.65201282 |
| 104 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.64846313 |
| 105 | inositol phosphate-mediated signaling (GO:0048016) | 2.61949878 |
| 106 | neuron-neuron synaptic transmission (GO:0007270) | 2.61754007 |
| 107 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.61350406 |
| 108 | negative regulation of glial cell differentiation (GO:0045686) | 2.60023985 |
| 109 | astrocyte development (GO:0014002) | 2.59206733 |
| 110 | eye photoreceptor cell differentiation (GO:0001754) | 2.58984211 |
| 111 | photoreceptor cell differentiation (GO:0046530) | 2.58984211 |
| 112 | transmission of nerve impulse (GO:0019226) | 2.58136746 |
| 113 | lung epithelium development (GO:0060428) | 2.57247345 |
| 114 | cyclic-nucleotide-mediated signaling (GO:0019935) | 2.56505876 |
| 115 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.56184056 |
| 116 | neurotransmitter uptake (GO:0001504) | 2.55737656 |
| 117 | vitamin A metabolic process (GO:0006776) | 2.54045533 |
| 118 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.53434331 |
| 119 | one-carbon compound transport (GO:0019755) | 2.53222744 |
| 120 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.52163280 |
| 121 | neurotransmitter secretion (GO:0007269) | 2.52073803 |
| 122 | surfactant homeostasis (GO:0043129) | 2.51528411 |
| 123 | neuron cell-cell adhesion (GO:0007158) | 2.50185570 |
| 124 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G- | 2.50171643 |
| 125 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.49536181 |
| 126 | L-glutamate transport (GO:0015813) | 2.48706748 |
| 127 | positive regulation of muscle hypertrophy (GO:0014742) | 2.48199766 |
| 128 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.48199766 |
| 129 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.47950318 |
| 130 | low-density lipoprotein particle remodeling (GO:0034374) | 2.47563467 |
| 131 | cell communication by electrical coupling (GO:0010644) | 2.47409789 |
| 132 | artery smooth muscle contraction (GO:0014824) | 2.47208415 |
| 133 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.47177631 |
| 134 | regulation of timing of cell differentiation (GO:0048505) | 2.46825318 |
| 135 | neuronal action potential propagation (GO:0019227) | 2.46007197 |
| 136 | trabecula morphogenesis (GO:0061383) | 2.44411166 |
| 137 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.43541798 |
| 138 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.43343512 |
| 139 | L-amino acid transport (GO:0015807) | 2.41877761 |
| 140 | regulation of phospholipid biosynthetic process (GO:0071071) | 2.41668121 |
| 141 | glutamate secretion (GO:0014047) | 2.39733904 |
| 142 | neutral amino acid transport (GO:0015804) | 2.38901889 |
| 143 | regulation of positive chemotaxis (GO:0050926) | 2.38814969 |
| 144 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.38598663 |
| 145 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.38281233 |
| 146 | mitochondrion distribution (GO:0048311) | 2.36859842 |
| 147 | nucleotide transmembrane transport (GO:1901679) | 2.35227577 |
| 148 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.35107569 |
| 149 | sodium ion export (GO:0071436) | 2.34432881 |
| 150 | dermatan sulfate metabolic process (GO:0030205) | 2.33893709 |
| 151 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 2.33720531 |
| 152 | lymphangiogenesis (GO:0001946) | 2.33395460 |
| 153 | potassium ion homeostasis (GO:0055075) | 2.33128401 |
| 154 | synaptic transmission, glutamatergic (GO:0035249) | 2.32282919 |
| 155 | postsynaptic membrane organization (GO:0001941) | 2.31515062 |
| 156 | sprouting angiogenesis (GO:0002040) | 2.31167317 |
| 157 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.31138864 |
| 158 | Notch signaling involved in heart development (GO:0061314) | 2.30224238 |
| 159 | retinal ganglion cell axon guidance (GO:0031290) | 2.29990201 |
| 160 | axonal fasciculation (GO:0007413) | 2.29848363 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.87013021 |
| 2 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.81208410 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.79121766 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.78931599 |
| 5 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.73951158 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.66525638 |
| 7 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.66308365 |
| 8 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.65750778 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.54503201 |
| 10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.54503201 |
| 11 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.45397923 |
| 12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.43949389 |
| 13 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.30273012 |
| 14 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.28627761 |
| 15 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.27886836 |
| 16 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.26791372 |
| 17 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.25980893 |
| 18 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.24492736 |
| 19 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.12534179 |
| 20 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.11663765 |
| 21 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.09914882 |
| 22 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.98106870 |
| 23 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.96724070 |
| 24 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.93374185 |
| 25 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.92280484 |
| 26 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.91993388 |
| 27 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.88197789 |
| 28 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.87036216 |
| 29 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.84619857 |
| 30 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.79098479 |
| 31 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.74158322 |
| 32 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.69038330 |
| 33 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.64409025 |
| 34 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.64178889 |
| 35 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.62630549 |
| 36 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.51062620 |
| 37 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.51062620 |
| 38 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.49612624 |
| 39 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.46287688 |
| 40 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.43464539 |
| 41 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.40554186 |
| 42 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.39333491 |
| 43 | P300_19829295_ChIP-Seq_ESCs_Human | 1.39057786 |
| 44 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.38823095 |
| 45 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.36901879 |
| 46 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.36696499 |
| 47 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.36015243 |
| 48 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.35552178 |
| 49 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.34762113 |
| 50 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.34667728 |
| 51 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.33305514 |
| 52 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.32386163 |
| 53 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.30723831 |
| 54 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.30501923 |
| 55 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.29749018 |
| 56 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.29238110 |
| 57 | EWS_26573619_Chip-Seq_HEK293_Human | 1.29040058 |
| 58 | TCF4_23295773_ChIP-Seq_U87_Human | 1.28027113 |
| 59 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.27139806 |
| 60 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.26978386 |
| 61 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.25959666 |
| 62 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.25351372 |
| 63 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.24957049 |
| 64 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.24619598 |
| 65 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.23481264 |
| 66 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.23226202 |
| 67 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.23162263 |
| 68 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.21275904 |
| 69 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.21118821 |
| 70 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.20307474 |
| 71 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.20251499 |
| 72 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.19158648 |
| 73 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.18043955 |
| 74 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.17828250 |
| 75 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.16637076 |
| 76 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.12048537 |
| 77 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.11755349 |
| 78 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.11686538 |
| 79 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.11528372 |
| 80 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.10961900 |
| 81 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.10593054 |
| 82 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.10580007 |
| 83 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.10142036 |
| 84 | JUN_21703547_ChIP-Seq_K562_Human | 1.10036890 |
| 85 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.08864757 |
| 86 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.08189003 |
| 87 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.06260207 |
| 88 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.06238144 |
| 89 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.05168440 |
| 90 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.04906910 |
| 91 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.04328801 |
| 92 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.04234526 |
| 93 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04185598 |
| 94 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.04129138 |
| 95 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.03789670 |
| 96 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.02807616 |
| 97 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.00267488 |
| 98 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.99895747 |
| 99 | KDM2B_26808549_Chip-Seq_REH_Human | 0.99670544 |
| 100 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.98819098 |
| 101 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.98523336 |
| 102 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.98523336 |
| 103 | FUS_26573619_Chip-Seq_HEK293_Human | 0.98366643 |
| 104 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.97207078 |
| 105 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.97173964 |
| 106 | * RXR_22108803_ChIP-Seq_LS180_Human | 0.96876277 |
| 107 | STAT3_23295773_ChIP-Seq_U87_Human | 0.96762885 |
| 108 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.96583329 |
| 109 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.96213877 |
| 110 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.95983280 |
| 111 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.95750036 |
| 112 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.95717449 |
| 113 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.95161247 |
| 114 | TP53_16413492_ChIP-PET_HCT116_Human | 0.94231460 |
| 115 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.94180699 |
| 116 | * AR_19668381_ChIP-Seq_PC3_Human | 0.92963882 |
| 117 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91967581 |
| 118 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.91518755 |
| 119 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.91180140 |
| 120 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.90345446 |
| 121 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.89268335 |
| 122 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.89083655 |
| 123 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.88806873 |
| 124 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.87577171 |
| 125 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85343264 |
| 126 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.83922001 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005167_abnormal_blood-brain_barrier | 4.30149627 |
| 2 | MP0003011_delayed_dark_adaptation | 3.49198755 |
| 3 | MP0001879_abnormal_lymphatic_vessel | 3.15343624 |
| 4 | MP0004859_abnormal_synaptic_plasticity | 3.01179722 |
| 5 | MP0005377_hearing/vestibular/ear_phenot | 2.67358473 |
| 6 | MP0003878_abnormal_ear_physiology | 2.67358473 |
| 7 | MP0003690_abnormal_glial_cell | 2.51705230 |
| 8 | MP0009384_cardiac_valve_regurgitation | 2.38385960 |
| 9 | MP0004885_abnormal_endolymph | 2.37472433 |
| 10 | MP0009379_abnormal_foot_pigmentation | 2.33814708 |
| 11 | MP0001486_abnormal_startle_reflex | 2.27316599 |
| 12 | MP0004272_abnormal_basement_membrane | 2.23812467 |
| 13 | MP0005171_absent_coat_pigmentation | 2.21536051 |
| 14 | MP0003880_abnormal_central_pattern | 2.18577418 |
| 15 | MP0005646_abnormal_pituitary_gland | 2.18264002 |
| 16 | MP0003635_abnormal_synaptic_transmissio | 2.11398674 |
| 17 | MP0001984_abnormal_olfaction | 2.01740487 |
| 18 | MP0003868_abnormal_feces_composition | 1.98813666 |
| 19 | MP0001958_emphysema | 1.97698776 |
| 20 | MP0002127_abnormal_cardiovascular_syste | 1.93835412 |
| 21 | MP0009780_abnormal_chondrocyte_physiolo | 1.93789710 |
| 22 | MP0004270_analgesia | 1.91762457 |
| 23 | MP0003633_abnormal_nervous_system | 1.87338361 |
| 24 | MP0006072_abnormal_retinal_apoptosis | 1.83923669 |
| 25 | MP0002254_reproductive_system_inflammat | 1.83171401 |
| 26 | MP0002064_seizures | 1.82015823 |
| 27 | MP0003329_amyloid_beta_deposits | 1.80123880 |
| 28 | MP0003279_aneurysm | 1.73074273 |
| 29 | MP0001188_hyperpigmentation | 1.72414920 |
| 30 | MP0005423_abnormal_somatic_nervous | 1.71921401 |
| 31 | MP0002063_abnormal_learning/memory/cond | 1.71322612 |
| 32 | MP0005623_abnormal_meninges_morphology | 1.70235684 |
| 33 | MP0009745_abnormal_behavioral_response | 1.67374329 |
| 34 | MP0002822_catalepsy | 1.64529239 |
| 35 | MP0004484_altered_response_of | 1.63801571 |
| 36 | MP0002234_abnormal_pharynx_morphology | 1.63157975 |
| 37 | MP0002735_abnormal_chemical_nociception | 1.62395526 |
| 38 | MP0002572_abnormal_emotion/affect_behav | 1.62200937 |
| 39 | MP0005248_abnormal_Harderian_gland | 1.60112812 |
| 40 | MP0001986_abnormal_taste_sensitivity | 1.58141655 |
| 41 | MP0005595_abnormal_vascular_smooth | 1.54860138 |
| 42 | MP0002009_preneoplasia | 1.52459372 |
| 43 | MP0003631_nervous_system_phenotype | 1.50890103 |
| 44 | MP0004215_abnormal_myocardial_fiber | 1.50595263 |
| 45 | MP0004147_increased_porphyrin_level | 1.50349633 |
| 46 | MP0001440_abnormal_grooming_behavior | 1.48104154 |
| 47 | MP0009046_muscle_twitch | 1.47704912 |
| 48 | MP0005409_darkened_coat_color | 1.47055633 |
| 49 | MP0005551_abnormal_eye_electrophysiolog | 1.46672682 |
| 50 | MP0005165_increased_susceptibility_to | 1.45563192 |
| 51 | MP0008569_lethality_at_weaning | 1.44034276 |
| 52 | MP0005187_abnormal_penis_morphology | 1.38417293 |
| 53 | MP0001968_abnormal_touch/_nociception | 1.37537801 |
| 54 | MP0006292_abnormal_olfactory_placode | 1.37109043 |
| 55 | MP0005084_abnormal_gallbladder_morpholo | 1.36995597 |
| 56 | MP0009697_abnormal_copulation | 1.33810082 |
| 57 | MP0000778_abnormal_nervous_system | 1.33476715 |
| 58 | MP0002734_abnormal_mechanical_nocicepti | 1.32427482 |
| 59 | MP0000566_synostosis | 1.30144562 |
| 60 | MP0002557_abnormal_social/conspecific_i | 1.28071252 |
| 61 | MP0001502_abnormal_circadian_rhythm | 1.27610690 |
| 62 | MP0010368_abnormal_lymphatic_system | 1.25274344 |
| 63 | MP0006138_congestive_heart_failure | 1.22851645 |
| 64 | MP0005253_abnormal_eye_physiology | 1.22595667 |
| 65 | MP0002295_abnormal_pulmonary_circulatio | 1.21398197 |
| 66 | MP0009278_abnormal_bone_marrow | 1.21296139 |
| 67 | MP0001485_abnormal_pinna_reflex | 1.21254860 |
| 68 | MP0001501_abnormal_sleep_pattern | 1.20914546 |
| 69 | MP0002272_abnormal_nervous_system | 1.20850394 |
| 70 | MP0002736_abnormal_nociception_after | 1.20775301 |
| 71 | MP0001905_abnormal_dopamine_level | 1.20214079 |
| 72 | MP0000049_abnormal_middle_ear | 1.19331059 |
| 73 | MP0002249_abnormal_larynx_morphology | 1.18439148 |
| 74 | MP0000462_abnormal_digestive_system | 1.18348184 |
| 75 | MP0005391_vision/eye_phenotype | 1.17862150 |
| 76 | MP0004019_abnormal_vitamin_homeostasis | 1.16979273 |
| 77 | MP0005386_behavior/neurological_phenoty | 1.14971783 |
| 78 | MP0004924_abnormal_behavior | 1.14971783 |
| 79 | MP0003634_abnormal_glial_cell | 1.12952716 |
| 80 | MP0006276_abnormal_autonomic_nervous | 1.11869933 |
| 81 | MP0000613_abnormal_salivary_gland | 1.10104266 |
| 82 | MP0008789_abnormal_olfactory_epithelium | 1.08185808 |
| 83 | MP0001346_abnormal_lacrimal_gland | 1.08056845 |
| 84 | MP0002108_abnormal_muscle_morphology | 1.07748056 |
| 85 | MP0004883_abnormal_blood_vessel | 1.07686178 |
| 86 | MP0005195_abnormal_posterior_eye | 1.06659850 |
| 87 | MP0000516_abnormal_urinary_system | 1.06652124 |
| 88 | MP0005367_renal/urinary_system_phenotyp | 1.06652124 |
| 89 | MP0002752_abnormal_somatic_nervous | 1.06602380 |
| 90 | MP0001529_abnormal_vocalization | 1.05669607 |
| 91 | MP0001963_abnormal_hearing_physiology | 1.05484049 |
| 92 | MP0003122_maternal_imprinting | 1.04455326 |
| 93 | MP0004858_abnormal_nervous_system | 1.04310582 |
| 94 | MP0004142_abnormal_muscle_tone | 1.03200939 |
| 95 | MP0004085_abnormal_heartbeat | 1.01693017 |
| 96 | MP0002638_abnormal_pupillary_reflex | 1.01139627 |
| 97 | MP0000631_abnormal_neuroendocrine_gland | 1.01011011 |
| 98 | MP0003137_abnormal_impulse_conducting | 1.00907859 |
| 99 | MP0000534_abnormal_ureter_morphology | 1.00162961 |
| 100 | MP0002066_abnormal_motor_capabilities/c | 0.98897335 |
| 101 | MP0002733_abnormal_thermal_nociception | 0.98630900 |
| 102 | MP0002067_abnormal_sensory_capabilities | 0.98470931 |
| 103 | MP0003787_abnormal_imprinting | 0.98026154 |
| 104 | MP0000013_abnormal_adipose_tissue | 0.97297684 |
| 105 | MP0000249_abnormal_blood_vessel | 0.94983859 |
| 106 | MP0003632_abnormal_nervous_system | 0.94888121 |
| 107 | MP0009250_abnormal_appendicular_skeleto | 0.93546995 |
| 108 | MP0002090_abnormal_vision | 0.91954644 |
| 109 | MP0003136_yellow_coat_color | 0.90224170 |
| 110 | MP0005394_taste/olfaction_phenotype | 0.90078196 |
| 111 | MP0005499_abnormal_olfactory_system | 0.90078196 |
| 112 | MP0008004_abnormal_stomach_pH | 0.89892645 |
| 113 | MP0002972_abnormal_cardiac_muscle | 0.88612105 |
| 114 | MP0000920_abnormal_myelination | 0.88561730 |
| 115 | MP0002233_abnormal_nose_morphology | 0.87012229 |
| 116 | MP0005164_abnormal_response_to | 0.86092068 |
| 117 | MP0001970_abnormal_pain_threshold | 0.85164219 |
| 118 | MP0004811_abnormal_neuron_physiology | 0.83263045 |
| 119 | MP0002152_abnormal_brain_morphology | 0.82602084 |
| 120 | MP0001177_atelectasis | 0.82430099 |
| 121 | MP0002184_abnormal_innervation | 0.82200885 |
| 122 | MP0002928_abnormal_bile_duct | 0.81650971 |
| 123 | MP0000026_abnormal_inner_ear | 0.81518584 |
| 124 | MP0003638_abnormal_response/metabolism_ | 0.81432832 |
| 125 | MP0003937_abnormal_limbs/digits/tail_de | 0.81206421 |
| 126 | MP0009053_abnormal_anal_canal | 0.80407594 |
| 127 | MP0002882_abnormal_neuron_morphology | 0.80277175 |
| 128 | MP0002332_abnormal_exercise_endurance | 0.79350842 |
| 129 | MP0000537_abnormal_urethra_morphology | 0.79160046 |
| 130 | MP0000955_abnormal_spinal_cord | 0.78309175 |
| 131 | MP0000372_irregular_coat_pigmentation | 0.77849909 |
| 132 | MP0002229_neurodegeneration | 0.77223628 |
| 133 | MP0001873_stomach_inflammation | 0.76856370 |
| 134 | MP0004742_abnormal_vestibular_system | 0.76653058 |
| 135 | MP0003075_altered_response_to | 0.76524652 |
| 136 | MP0003119_abnormal_digestive_system | 0.75162858 |
| 137 | MP0005620_abnormal_muscle_contractility | 0.73918707 |
| 138 | MP0003938_abnormal_ear_development | 0.73786541 |
| 139 | MP0000538_abnormal_urinary_bladder | 0.68565994 |
| 140 | MP0000647_abnormal_sebaceous_gland | 0.66552445 |
| 141 | MP0000579_abnormal_nail_morphology | 0.65231723 |
| 142 | MP0004043_abnormal_pH_regulation | 0.63613547 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hemiparesis (HP:0001269) | 6.09651999 |
| 2 | Aplasia involving bones of the upper limbs (HP:0009823) | 5.55161079 |
| 3 | Aplasia of the phalanges of the hand (HP:0009802) | 5.55161079 |
| 4 | Aplasia involving bones of the extremities (HP:0009825) | 5.55161079 |
| 5 | Abnormality of the axillary hair (HP:0100134) | 5.22733454 |
| 6 | Abnormality of secondary sexual hair (HP:0009888) | 5.22733454 |
| 7 | Onycholysis (HP:0001806) | 5.20556390 |
| 8 | Adactyly (HP:0009776) | 4.96894431 |
| 9 | Abnormality of binocular vision (HP:0011514) | 4.90586484 |
| 10 | Diplopia (HP:0000651) | 4.90586484 |
| 11 | Megalencephaly (HP:0001355) | 4.26775309 |
| 12 | Neurofibrillary tangles (HP:0002185) | 3.77877976 |
| 13 | Epileptic encephalopathy (HP:0200134) | 3.47044225 |
| 14 | Hypoglycemic seizures (HP:0002173) | 3.46554628 |
| 15 | Confusion (HP:0001289) | 3.30610981 |
| 16 | Hypoplastic left heart (HP:0004383) | 3.23406580 |
| 17 | Hypoglycemic coma (HP:0001325) | 3.22347624 |
| 18 | Focal motor seizures (HP:0011153) | 3.19700407 |
| 19 | Broad-based gait (HP:0002136) | 3.11333045 |
| 20 | Hemiplegia (HP:0002301) | 3.10914756 |
| 21 | Drooling (HP:0002307) | 3.09800457 |
| 22 | Abnormality of the dental root (HP:0006486) | 3.07041028 |
| 23 | Taurodontia (HP:0000679) | 3.07041028 |
| 24 | Abnormality of permanent molar morphology (HP:0011071) | 3.07041028 |
| 25 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.04548016 |
| 26 | Abnormality of the dental pulp (HP:0006479) | 3.04445801 |
| 27 | Hepatoblastoma (HP:0002884) | 3.02324892 |
| 28 | Gait imbalance (HP:0002141) | 2.97521341 |
| 29 | Portal hypertension (HP:0001409) | 2.96870444 |
| 30 | Stomach cancer (HP:0012126) | 2.95581736 |
| 31 | Hypoalphalipoproteinemia (HP:0003233) | 2.92477354 |
| 32 | Poor eye contact (HP:0000817) | 2.89075030 |
| 33 | Colon cancer (HP:0003003) | 2.87125005 |
| 34 | Abnormality of molar morphology (HP:0011070) | 2.85265286 |
| 35 | Abnormality of molar (HP:0011077) | 2.85265286 |
| 36 | Absent hand (HP:0004050) | 2.85195725 |
| 37 | Excessive salivation (HP:0003781) | 2.84816873 |
| 38 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.84527001 |
| 39 | Febrile seizures (HP:0002373) | 2.83383701 |
| 40 | Exercise-induced muscle cramps (HP:0003710) | 2.79570408 |
| 41 | Neoplasm of the oral cavity (HP:0100649) | 2.75283989 |
| 42 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.73888396 |
| 43 | Vascular calcification (HP:0004934) | 2.73763437 |
| 44 | Chronic hepatic failure (HP:0100626) | 2.73374004 |
| 45 | Hyperphosphatemia (HP:0002905) | 2.72417393 |
| 46 | Epidermoid cyst (HP:0200040) | 2.71977963 |
| 47 | Short hallux (HP:0010109) | 2.68793401 |
| 48 | Abnormality of the hepatic vasculature (HP:0006707) | 2.66736762 |
| 49 | Focal seizures (HP:0007359) | 2.64983451 |
| 50 | Cerebral inclusion bodies (HP:0100314) | 2.61478474 |
| 51 | Protruding tongue (HP:0010808) | 2.60165911 |
| 52 | True hermaphroditism (HP:0010459) | 2.58631555 |
| 53 | Abnormality of renal resorption (HP:0011038) | 2.57536274 |
| 54 | Increased CSF protein (HP:0002922) | 2.56837090 |
| 55 | Ulnar claw (HP:0001178) | 2.55249656 |
| 56 | Congenital primary aphakia (HP:0007707) | 2.52468498 |
| 57 | Medial flaring of the eyebrow (HP:0010747) | 2.51506167 |
| 58 | Esophageal varix (HP:0002040) | 2.50828594 |
| 59 | Neoplasm of the adrenal cortex (HP:0100641) | 2.50318178 |
| 60 | Nephrogenic diabetes insipidus (HP:0009806) | 2.48757757 |
| 61 | Clumsiness (HP:0002312) | 2.45779275 |
| 62 | Hypoplasia of the uterus (HP:0000013) | 2.44770522 |
| 63 | Subacute progressive viral hepatitis (HP:0006572) | 2.44368449 |
| 64 | Medulloblastoma (HP:0002885) | 2.43443691 |
| 65 | Hypoplastic heart (HP:0001961) | 2.42917140 |
| 66 | Genital tract atresia (HP:0001827) | 2.41872596 |
| 67 | Status epilepticus (HP:0002133) | 2.40597707 |
| 68 | Abnormality of nail color (HP:0100643) | 2.39822664 |
| 69 | Tubulointerstitial nephritis (HP:0001970) | 2.39722757 |
| 70 | Hyperventilation (HP:0002883) | 2.37793564 |
| 71 | Impaired social interactions (HP:0000735) | 2.36870860 |
| 72 | Abnormal social behavior (HP:0012433) | 2.36870860 |
| 73 | Cardiovascular calcification (HP:0011915) | 2.35425210 |
| 74 | Symptomatic seizures (HP:0011145) | 2.34122344 |
| 75 | Papillary thyroid carcinoma (HP:0002895) | 2.34105458 |
| 76 | Vascular tortuosity (HP:0004948) | 2.32932322 |
| 77 | Absent toe (HP:0010760) | 2.31069162 |
| 78 | Myokymia (HP:0002411) | 2.29870357 |
| 79 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.28886587 |
| 80 | Dysdiadochokinesis (HP:0002075) | 2.28703070 |
| 81 | Vaginal atresia (HP:0000148) | 2.28655511 |
| 82 | Absent hair (HP:0002298) | 2.28121377 |
| 83 | Annular pancreas (HP:0001734) | 2.23759268 |
| 84 | Cranial hyperostosis (HP:0004437) | 2.23388936 |
| 85 | Glioma (HP:0009733) | 2.21830832 |
| 86 | Cone-rod dystrophy (HP:0000548) | 2.21563876 |
| 87 | Inability to walk (HP:0002540) | 2.21076553 |
| 88 | Mixed hearing impairment (HP:0000410) | 2.20922396 |
| 89 | Astrocytoma (HP:0009592) | 2.19052862 |
| 90 | Abnormality of the astrocytes (HP:0100707) | 2.19052862 |
| 91 | Keratoconus (HP:0000563) | 2.18092620 |
| 92 | Increased corneal curvature (HP:0100692) | 2.18092620 |
| 93 | Dialeptic seizures (HP:0011146) | 2.15863356 |
| 94 | Abnormal eating behavior (HP:0100738) | 2.14352589 |
| 95 | Arterial tortuosity (HP:0005116) | 2.13136293 |
| 96 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.11382710 |
| 97 | Absent speech (HP:0001344) | 2.09140253 |
| 98 | Tetraplegia (HP:0002445) | 2.08222947 |
| 99 | Decreased central vision (HP:0007663) | 2.08091393 |
| 100 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.07258879 |
| 101 | Capillary hemangiomas (HP:0005306) | 2.04349178 |
| 102 | Intellectual disability, severe (HP:0010864) | 2.03785573 |
| 103 | Choroideremia (HP:0001139) | 2.03407885 |
| 104 | Broad foot (HP:0001769) | 2.01799636 |
| 105 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.00832626 |
| 106 | Polycythemia (HP:0001901) | 1.99346654 |
| 107 | Long nose (HP:0003189) | 1.99337429 |
| 108 | Retinal dysplasia (HP:0007973) | 1.96965368 |
| 109 | Abnormality of renal excretion (HP:0011036) | 1.95363762 |
| 110 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.95331730 |
| 111 | Absent/shortened dynein arms (HP:0200106) | 1.95331730 |
| 112 | Fibular aplasia (HP:0002990) | 1.95309410 |
| 113 | Absence seizures (HP:0002121) | 1.95042196 |
| 114 | Polyphagia (HP:0002591) | 1.94403576 |
| 115 | Preaxial foot polydactyly (HP:0001841) | 1.93591556 |
| 116 | Type II lissencephaly (HP:0007260) | 1.90757049 |
| 117 | Limb dystonia (HP:0002451) | 1.89365458 |
| 118 | Ankle clonus (HP:0011448) | 1.88352453 |
| 119 | Palpebral edema (HP:0100540) | 1.87792682 |
| 120 | Stereotypic behavior (HP:0000733) | 1.87698692 |
| 121 | Optic nerve hypoplasia (HP:0000609) | 1.87398186 |
| 122 | Supranuclear gaze palsy (HP:0000605) | 1.86750601 |
| 123 | Postural tremor (HP:0002174) | 1.86442553 |
| 124 | Menstrual irregularities (HP:0000858) | 1.86001957 |
| 125 | Postural instability (HP:0002172) | 1.81068225 |
| 126 | Truncal ataxia (HP:0002078) | 1.80631037 |
| 127 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.80072410 |
| 128 | Pancreatic fibrosis (HP:0100732) | 1.79618035 |
| 129 | Abnormality of the aortic arch (HP:0012303) | 1.79547904 |
| 130 | Gaze-evoked nystagmus (HP:0000640) | 1.79499289 |
| 131 | Alacrima (HP:0000522) | 1.79024717 |
| 132 | Chorioretinal atrophy (HP:0000533) | 1.78388304 |
| 133 | Large earlobe (HP:0009748) | 1.77865849 |
| 134 | Craniofacial hyperostosis (HP:0004493) | 1.77430785 |
| 135 | Hamartoma (HP:0010566) | 1.76859071 |
| 136 | Atonic seizures (HP:0010819) | 1.76014149 |
| 137 | Spastic tetraparesis (HP:0001285) | 1.75758621 |
| 138 | Pseudobulbar signs (HP:0002200) | 1.75630247 |
| 139 | Agitation (HP:0000713) | 1.75591580 |
| 140 | Acanthosis nigricans (HP:0000956) | 1.75396213 |
| 141 | Stenosis of the external auditory canal (HP:0000402) | 1.75395465 |
| 142 | Peripheral hypomyelination (HP:0007182) | 1.73965195 |
| 143 | Retinal atrophy (HP:0001105) | 1.73548409 |
| 144 | Hypoplasia of the corpus callosum (HP:0002079) | 1.72217522 |
| 145 | Broad alveolar ridges (HP:0000187) | 1.71768023 |
| 146 | Hypoplasia of dental enamel (HP:0006297) | 1.70851540 |
| 147 | Attenuation of retinal blood vessels (HP:0007843) | 1.70490737 |
| 148 | Dyskinesia (HP:0100660) | 1.70409408 |
| 149 | Prolonged QT interval (HP:0001657) | 1.70190617 |
| 150 | Congenital stationary night blindness (HP:0007642) | 1.68905781 |
| 151 | Pachygyria (HP:0001302) | 1.67321207 |
| 152 | Thickened helices (HP:0000391) | 1.67313041 |
| 153 | Synostosis involving the elbow (HP:0003938) | 1.66019915 |
| 154 | Humeroradial synostosis (HP:0003041) | 1.66019915 |
| 155 | Mutism (HP:0002300) | 1.65121394 |
| 156 | Gastroesophageal reflux (HP:0002020) | 1.63981846 |
| 157 | Specific learning disability (HP:0001328) | 1.63965698 |
| 158 | Abnormality of salivation (HP:0100755) | 1.63780719 |
| 159 | Abnormality of the ischium (HP:0003174) | 1.63439755 |
| 160 | Vitreoretinal degeneration (HP:0000655) | 1.63304945 |
| 161 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 1.63226171 |
| 162 | Generalized tonic-clonic seizures (HP:0002069) | 1.61989527 |
| 163 | Bronchomalacia (HP:0002780) | 1.61864990 |
| 164 | Progressive cerebellar ataxia (HP:0002073) | 1.61633715 |
| 165 | Gastrointestinal atresia (HP:0002589) | 1.61411559 |
| 166 | Axonal loss (HP:0003447) | 1.61023113 |
| 167 | Supernumerary spleens (HP:0009799) | 1.60667362 |
| 168 | Tetraparesis (HP:0002273) | 1.59613143 |
| 169 | Split foot (HP:0001839) | 1.58307481 |
| 170 | Subcapsular cataract (HP:0000523) | 1.57146565 |
| 171 | Visual hallucinations (HP:0002367) | 1.56757075 |
| 172 | Action tremor (HP:0002345) | 1.56345981 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 4.91984164 |
| 2 | KDR | 4.41121600 |
| 3 | MUSK | 4.27287720 |
| 4 | EPHA4 | 3.95187475 |
| 5 | GRK1 | 3.62381576 |
| 6 | NTRK2 | 3.13526279 |
| 7 | TNIK | 2.80705293 |
| 8 | INSRR | 2.77660149 |
| 9 | CASK | 2.73876201 |
| 10 | WNK3 | 2.20332615 |
| 11 | PHKG1 | 2.12458356 |
| 12 | PHKG2 | 2.12458356 |
| 13 | NTRK3 | 1.90453384 |
| 14 | FRK | 1.90226961 |
| 15 | CSNK1A1L | 1.85778393 |
| 16 | CSNK1G3 | 1.70152234 |
| 17 | PTK6 | 1.63765076 |
| 18 | CSNK1G1 | 1.57769524 |
| 19 | PTK2B | 1.48286962 |
| 20 | STK39 | 1.47377183 |
| 21 | LMTK2 | 1.41467856 |
| 22 | MARK1 | 1.39655085 |
| 23 | RAF1 | 1.38938794 |
| 24 | DMPK | 1.34581246 |
| 25 | PINK1 | 1.32858880 |
| 26 | NLK | 1.32794166 |
| 27 | WEE1 | 1.32492835 |
| 28 | MAPK12 | 1.30217624 |
| 29 | MST4 | 1.29995817 |
| 30 | FGR | 1.24018493 |
| 31 | AKT3 | 1.23328218 |
| 32 | MAP4K2 | 1.18715133 |
| 33 | PRKCE | 1.16536423 |
| 34 | ROCK1 | 1.13499189 |
| 35 | NTRK1 | 1.12362217 |
| 36 | UHMK1 | 1.10102238 |
| 37 | FES | 1.07662335 |
| 38 | FGFR2 | 1.07575086 |
| 39 | PRKCG | 1.04181334 |
| 40 | NUAK1 | 1.03452951 |
| 41 | MAPK7 | 1.01874300 |
| 42 | MINK1 | 1.01224398 |
| 43 | PRPF4B | 1.00099547 |
| 44 | MAP3K4 | 0.99185900 |
| 45 | MAPK13 | 0.94514570 |
| 46 | PRKD3 | 0.91008955 |
| 47 | EPHA3 | 0.90493108 |
| 48 | PRKG2 | 0.88974303 |
| 49 | TRIB3 | 0.88950254 |
| 50 | PRKAA2 | 0.88709084 |
| 51 | IGF1R | 0.88220050 |
| 52 | CDK5 | 0.87269049 |
| 53 | MELK | 0.86495605 |
| 54 | MKNK2 | 0.86289051 |
| 55 | STK38L | 0.82715510 |
| 56 | CAMKK1 | 0.81545002 |
| 57 | DYRK2 | 0.80606980 |
| 58 | PRKCQ | 0.80589356 |
| 59 | MAP2K7 | 0.80110493 |
| 60 | KSR1 | 0.78456828 |
| 61 | CAMK1G | 0.77469671 |
| 62 | GRK5 | 0.75143192 |
| 63 | CAMK2A | 0.74429593 |
| 64 | MAPK15 | 0.73243352 |
| 65 | WNK4 | 0.71826562 |
| 66 | EPHB2 | 0.71615049 |
| 67 | SGK223 | 0.69826361 |
| 68 | SGK494 | 0.69826361 |
| 69 | MAP3K9 | 0.69616849 |
| 70 | PAK6 | 0.66912076 |
| 71 | MARK2 | 0.66081409 |
| 72 | PRKCH | 0.63660063 |
| 73 | INSR | 0.62891189 |
| 74 | BMX | 0.62509215 |
| 75 | PRKG1 | 0.61078563 |
| 76 | TGFBR2 | 0.60783229 |
| 77 | PNCK | 0.60747148 |
| 78 | SGK2 | 0.60458776 |
| 79 | DAPK2 | 0.58836767 |
| 80 | IRAK3 | 0.58269895 |
| 81 | CCNB1 | 0.58231799 |
| 82 | CSNK1G2 | 0.58185669 |
| 83 | MAP2K2 | 0.56217838 |
| 84 | CSNK1A1 | 0.55773281 |
| 85 | WNK1 | 0.55527701 |
| 86 | STK11 | 0.55224309 |
| 87 | RIPK4 | 0.54292257 |
| 88 | RET | 0.54016052 |
| 89 | SRC | 0.53826914 |
| 90 | MAPKAPK5 | 0.53687322 |
| 91 | OXSR1 | 0.52990362 |
| 92 | CAMK1 | 0.52940133 |
| 93 | MAP2K1 | 0.52591456 |
| 94 | PBK | 0.52418614 |
| 95 | BMPR1B | 0.50852215 |
| 96 | ADRBK1 | 0.50687845 |
| 97 | PRKCA | 0.50403398 |
| 98 | TYRO3 | 0.50247254 |
| 99 | DYRK1A | 0.49886158 |
| 100 | CAMK2G | 0.48485650 |
| 101 | MAPK4 | 0.48096125 |
| 102 | EPHB1 | 0.47840944 |
| 103 | CAMK2D | 0.46631827 |
| 104 | PDPK1 | 0.45984792 |
| 105 | SGK1 | 0.45333318 |
| 106 | PAK3 | 0.44253998 |
| 107 | PRKCZ | 0.42405212 |
| 108 | BRSK2 | 0.42157568 |
| 109 | BMPR2 | 0.41877230 |
| 110 | PRKACA | 0.41858764 |
| 111 | GSK3A | 0.41010721 |
| 112 | CAMK2B | 0.40958053 |
| 113 | SIK2 | 0.40257383 |
| 114 | KSR2 | 0.39954531 |
| 115 | TSSK6 | 0.39940844 |
| 116 | PRKD1 | 0.39358892 |
| 117 | VRK1 | 0.39213236 |
| 118 | TEC | 0.37698371 |
| 119 | NEK9 | 0.37266885 |
| 120 | PRKAA1 | 0.36854698 |
| 121 | PKN1 | 0.36556393 |
| 122 | MAP3K12 | 0.36350894 |
| 123 | SIK1 | 0.36139802 |
| 124 | CSNK1D | 0.35703211 |
| 125 | RPS6KA3 | 0.35676507 |
| 126 | PRKACG | 0.33021393 |
| 127 | PLK2 | 0.32748011 |
| 128 | FYN | 0.32012973 |
| 129 | ERBB4 | 0.31891085 |
| 130 | NEK6 | 0.31859078 |
| 131 | CDK3 | 0.31375899 |
| 132 | MAPK10 | 0.30943833 |
| 133 | ROCK2 | 0.29910477 |
| 134 | EIF2AK1 | 0.29582405 |
| 135 | PRKDC | 0.29398308 |
| 136 | ERBB2 | 0.29070091 |
| 137 | FER | 0.28440847 |
| 138 | EIF2AK2 | 0.27788979 |
| 139 | SGK3 | 0.25988269 |
| 140 | BRSK1 | 0.25824835 |
| 141 | VRK2 | 0.24552878 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.17817655 |
| 2 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.71176551 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 2.39038186 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.32218574 |
| 5 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.27365354 |
| 6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.24175053 |
| 7 | Bile secretion_Homo sapiens_hsa04976 | 2.08679315 |
| 8 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.00992101 |
| 9 | Mineral absorption_Homo sapiens_hsa04978 | 1.91988358 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.87301311 |
| 11 | Morphine addiction_Homo sapiens_hsa05032 | 1.82030738 |
| 12 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.80999579 |
| 13 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.76372687 |
| 14 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.71637165 |
| 15 | Circadian entrainment_Homo sapiens_hsa04713 | 1.70618208 |
| 16 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.69008612 |
| 17 | Salivary secretion_Homo sapiens_hsa04970 | 1.68150051 |
| 18 | Insulin secretion_Homo sapiens_hsa04911 | 1.61203271 |
| 19 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.52669525 |
| 20 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.51321728 |
| 21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.41592405 |
| 22 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.37431535 |
| 23 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.36047675 |
| 24 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.34589309 |
| 25 | Cocaine addiction_Homo sapiens_hsa05030 | 1.32962005 |
| 26 | Long-term depression_Homo sapiens_hsa04730 | 1.31237598 |
| 27 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.30403862 |
| 28 | Phototransduction_Homo sapiens_hsa04744 | 1.30171201 |
| 29 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.29270092 |
| 30 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.26880188 |
| 31 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.25208742 |
| 32 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.19672360 |
| 33 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.19588053 |
| 34 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.17474690 |
| 35 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.17338288 |
| 36 | Histidine metabolism_Homo sapiens_hsa00340 | 1.17049573 |
| 37 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.16962872 |
| 38 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.15831789 |
| 39 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.15709395 |
| 40 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.15538257 |
| 41 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.15359638 |
| 42 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.13565419 |
| 43 | Long-term potentiation_Homo sapiens_hsa04720 | 1.08960383 |
| 44 | Olfactory transduction_Homo sapiens_hsa04740 | 1.08860629 |
| 45 | Axon guidance_Homo sapiens_hsa04360 | 1.07931410 |
| 46 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.06795601 |
| 47 | Melanogenesis_Homo sapiens_hsa04916 | 1.04401569 |
| 48 | Renin secretion_Homo sapiens_hsa04924 | 1.03918457 |
| 49 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.03455781 |
| 50 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.03436580 |
| 51 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.03119849 |
| 52 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.01089026 |
| 53 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.97482415 |
| 54 | Gap junction_Homo sapiens_hsa04540 | 0.97371111 |
| 55 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.95577648 |
| 56 | Taste transduction_Homo sapiens_hsa04742 | 0.95549850 |
| 57 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.94411624 |
| 58 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.93640005 |
| 59 | Adherens junction_Homo sapiens_hsa04520 | 0.88417369 |
| 60 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.88098590 |
| 61 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.85318181 |
| 62 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.84879755 |
| 63 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.84552901 |
| 64 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.84077026 |
| 65 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.83052937 |
| 66 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.82266094 |
| 67 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.81280977 |
| 68 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.80329035 |
| 69 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.79077112 |
| 70 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.78514086 |
| 71 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.78238118 |
| 72 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.77771358 |
| 73 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.76944394 |
| 74 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.74297568 |
| 75 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.73599502 |
| 76 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.73083811 |
| 77 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.72793028 |
| 78 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.71606252 |
| 79 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.71482448 |
| 80 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.71344657 |
| 81 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.70627453 |
| 82 | Focal adhesion_Homo sapiens_hsa04510 | 0.65349113 |
| 83 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.64576226 |
| 84 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.64532917 |
| 85 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.63684424 |
| 86 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.63363844 |
| 87 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.62815074 |
| 88 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.62421159 |
| 89 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.61339328 |
| 90 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.60946981 |
| 91 | Circadian rhythm_Homo sapiens_hsa04710 | 0.60438259 |
| 92 | Sulfur relay system_Homo sapiens_hsa04122 | 0.60194647 |
| 93 | Peroxisome_Homo sapiens_hsa04146 | 0.59777266 |
| 94 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.58103823 |
| 95 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.57418784 |
| 96 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.57016523 |
| 97 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.56854409 |
| 98 | ABC transporters_Homo sapiens_hsa02010 | 0.56647131 |
| 99 | Prion diseases_Homo sapiens_hsa05020 | 0.55997927 |
| 100 | Tight junction_Homo sapiens_hsa04530 | 0.54050910 |
| 101 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.53660593 |
| 102 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.52739354 |
| 103 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.51139434 |
| 104 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.50812392 |
| 105 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.50802857 |
| 106 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.50490911 |
| 107 | Endometrial cancer_Homo sapiens_hsa05213 | 0.47984387 |
| 108 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.47490800 |
| 109 | Retinol metabolism_Homo sapiens_hsa00830 | 0.45812897 |
| 110 | Glioma_Homo sapiens_hsa05214 | 0.45762310 |
| 111 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.44567839 |
| 112 | * Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.44223962 |
| 113 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.43677230 |
| 114 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.43064692 |
| 115 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.41522429 |
| 116 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.40479468 |
| 117 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.38721631 |
| 118 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.38313792 |
| 119 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.37897002 |
| 120 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.37527527 |
| 121 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.36777220 |
| 122 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.36676077 |
| 123 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.36050956 |
| 124 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.35754103 |
| 125 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.35506247 |
| 126 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.34600074 |
| 127 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.33587468 |

